RECURRENT OSTEOSARCOMA
Clinical trials for RECURRENT OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for RECURRENT OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged attack tested for Tough-to-Treat bone cancer in young people
Disease control Recruiting nowThis study is testing a combination of two drugs, atezolizumab and cabozantinib, to see if they can help control advanced osteosarcoma (a type of bone cancer) in adolescents and young adults. The trial is for patients aged 12 and older whose cancer has come back or spread after s…
Matched conditions: RECURRENT OSTEOSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for kids with tough cancers: experimental drug trial opens
Disease control Recruiting nowThis study is testing a new drug called tegavivint in children, teens, and young adults whose solid tumors or lymphomas have come back or haven't responded to other treatments. The main goals are to find the safest dose, understand the side effects, and see if the drug can help s…
Matched conditions: RECURRENT OSTEOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Scientists re-engineer Patient's own immune cells to fight incurable bone cancer
Disease control Recruiting nowThis early-stage trial is testing a new treatment called CAR T-cell therapy for patients with advanced osteosarcoma, a type of bone cancer that has come back or stopped responding to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better ta…
Matched conditions: RECURRENT OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New hope for kids with tough cancers: trial tests Double-Team drug strategy
Disease control Recruiting nowThis study is testing two different drug combinations to find safe doses and see if they can help control cancer in children and young adults whose solid tumors have come back or haven't responded to treatment. In the first part, participants will be assigned to receive either On…
Matched conditions: RECURRENT OSTEOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC